Tazarotene and corticosteroid treatment for psoriasis

Details Tazarotene and corticosteroid treatment for psoriasis Tazarotene and corticosteroid treatment for psoriasis

2004-04-07

2011-12-06

Badio, Barbara P (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

Reexamination Certificate

active

08071578

ABSTRACT:
The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis.

REFERENCES:
patent: 4775529 (1988-10-01), Sequeira et al.
patent: 5236906 (1993-08-01), Yamamoto
patent: 5650279 (1997-07-01), Nagpal et al.
patent: 5874074 (1999-02-01), Smith
patent: 5914334 (1999-06-01), Charu
Schwartz, Biological Abstracts, vol. 10, Philadelphia, PA, US; abstract No. 981998 & Journal of Investigative Dermatology, 102 (2). 1994. 241-246.

Affiliated with

Also associated with

Rating

Tazarotene and corticosteroid treatment for psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tazarotene and corticosteroid treatment for psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tazarotene and corticosteroid treatment for psoriasis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4263292